Role of ferrous iron chelator 2,2′-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage

View More View Less
  • 1 Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
USD  $45.00
USD  $515.00
USD  $612.00
Print or Print + Online Sign in

Object. Oxyhemoglobin (HbO2) causes vasospasm after subarachnoid hemorrhage (SAH). The most likely spasmogenic component of HbO2 is iron. Various iron chelators, such as deferoxamine, have prevented vasospasm in vivo with limited success. However, only chelators of iron in the ferric state have been studied in animal models of vasospasm after SAH. Because free radical formation requires the ferrous (Fe++) moiety and Fe++ is a potent binder of the vasodilator nitric oxide, the authors hypothesized that iron in the ferrous state causes vasospasm and that chelators of Fe++, such as 2,2′-dipyridyl, may prevent vasospasm. This study was undertaken to investigate the influence of 2,2′-dipyridyl on vasospasm after induction of SAH in a primate model.

Methods. Twelve cynomolgus monkeys were randomly divided into two groups and then both groups underwent placement of an arterial autologous blood clot in the subarachnoid space around the right middle cerebral artery (MCA). The five animals in the control group received intravenously administered saline and the seven treated animals received intravenously administered chelator (2,2′-dipyridyl) for 14 days. Sequential arteriography for assessment of MCA diameter was performed before and on the 7th day after SAH.

Conclusions. Prevention of cerebral vasospasm by means of treatment with continuous intravenous administration of 2,2′-dipyridyl is reported in a primate model of SAH. This result provides insight into the possible mechanism of delayed vasospasm after aneurysmal SAH and provides a potential preventive therapy for it.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
USD  $515.00
USD  $612.00
  • 1.

    Afshar JKB, , Pluta RM, & Boock RJ, et al: Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 83:118122, 1995 Afshar JKB, Pluta RM, Boock RJ, et al: Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 83:118–122, 1995

    • Search Google Scholar
    • Export Citation
  • 2.

    Asano T, , Matusi T, & Takuwa Y: Reappraisal of the role of lipid peroxidation in the pathogenesis of vasospasm: relevance to protein kinase C activation, in San K, , Takakura K, & Kassell NF, et al (eds): Cerebral Vasospasm. Proceedings of the IVth International Conference on Cerebral Vasospasm, Tokyo, 1990. Tokyo: University of Tokyo Press, 1990, pp 6570 Asano T, Matusi T, Takuwa Y: Reappraisal of the role of lipid peroxidation in the pathogenesis of vasospasm: relevance to protein kinase C activation, in San K, Takakura K, Kassell NF, et al (eds): Cerebral Vasospasm. Proceedings of the IVth International Conference on Cerebral Vasospasm, Tokyo, 1990. Tokyo: University of Tokyo Press, 1990, pp 65–70

    • Search Google Scholar
    • Export Citation
  • 3.

    Asano T, , Tanishima T, & Sasaki T, et al: Possible participation of free radical reactions initiated by clot lysis in the pathogenesis of vasospasm after subarachnoid hemorrhage, in Wilkins R (ed): Cerebral Arterial Spasm. Proceedings of the Second International Workshop. Amsterdam, The Netherlands, 1979. Baltimore: Williams & Wilkins, 1980, pp 190201 Asano T, Tanishima T, Sasaki T, et al: Possible participation of free radical reactions initiated by clot lysis in the pathogenesis of vasospasm after subarachnoid hemorrhage, in Wilkins R (ed): Cerebral Arterial Spasm. Proceedings of the Second International Workshop. Amsterdam, The Netherlands, 1979. Baltimore: Williams & Wilkins, 1980, pp 190–201

    • Search Google Scholar
    • Export Citation
  • 4.

    Balla G, , Vercellotti GM, & Muller-Eberhard U, et al: Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest 64:648655, 1991 Balla G, Vercellotti GM, Muller-Eberhard U, et al: Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest 64:648–655, 1991

    • Search Google Scholar
    • Export Citation
  • 5.

    Balla J, , Nath KA, & Balla G, et al: Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am J Physiol 268:L321L327, 1995 Balla J, Nath KA, Balla G, et al: Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am J Physiol 268:L321–L327, 1995

    • Search Google Scholar
    • Export Citation
  • 6.

    Breuer W, , Epsztejn S, & Cabantchik ZI: Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron (II). J Biol Chem 270:24092415, 1995 Breuer W, Epsztejn S, Cabantchik ZI: Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron (II). J Biol Chem 270:2409–2415, 1995

    • Search Google Scholar
    • Export Citation
  • 7.

    Cohen G: The Fenton reaction, in Greenwald RA (ed): CRC Handbook of Methods for Oxygen Radical Research. Boca Raton, FL:: CRC Press, 1985, pp 5558 Cohen G: The Fenton reaction, in Greenwald RA (ed): CRC Handbook of Methods for Oxygen Radical Research. Boca Raton, FL:: CRC Press, 1985, pp 55–58

    • Search Google Scholar
    • Export Citation
  • 8.

    Comair YG, , Schipper HM, & Brem S: The prevention of oxyhemoglobin-induced endothelial and smooth muscle cytoskeletal injury by deferoxamine. Neurosurgery 32:5865, 1993 Comair YG, Schipper HM, Brem S: The prevention of oxyhemoglobin-induced endothelial and smooth muscle cytoskeletal injury by deferoxamine. Neurosurgery 32:58–65, 1993

    • Search Google Scholar
    • Export Citation
  • 9.

    Crow A, & Morgan EH: Effects of chelators on iron uptake and release by the brain in the rat. Neurochem Res 19:7176, 1994 Crow A, Morgan EH: Effects of chelators on iron uptake and release by the brain in the rat. Neurochem Res 19:71–76, 1994

    • Search Google Scholar
    • Export Citation
  • 10.

    Duff TA, , Scott G, & Feilbach JA: Ultrastructural evidence of arterial denervation following experimental subarachnoid hemorrhage. J Neurosurg 64:292297, 1986 Duff TA, Scott G, Feilbach JA: Ultrastructural evidence of arterial denervation following experimental subarachnoid hemorrhage. J Neurosurg 64:292–297, 1986

    • Search Google Scholar
    • Export Citation
  • 11.

    Espinosa F, , Weir B, & Overton T, et al: A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 1: Clinical and radiological findings. J Neurosurg 60:11671175, 1984 Espinosa F, Weir B, Overton T, et al: A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 1: Clinical and radiological findings. J Neurosurg 60:1167–1175, 1984

    • Search Google Scholar
    • Export Citation
  • 12.

    Faraci FM: Endothelium-derived vasoactive factors and regulation of the cerebral circulation. Neurosurgery 33:648659, 1993 Faraci FM: Endothelium-derived vasoactive factors and regulation of the cerebral circulation. Neurosurgery 33:648–659, 1993

    • Search Google Scholar
    • Export Citation
  • 13.

    Fox JL: Intracranial vascular smooth muscle: a study with iron compounds. Surg Neurol 11:363368, 1979 Fox JL: Intracranial vascular smooth muscle: a study with iron compounds. Surg Neurol 11:363–368, 1979

    • Search Google Scholar
    • Export Citation
  • 14.

    Fuji S, & Fujitsu K: Experimental vasospasm in cultured arterial smooth-muscle cells. Part 1. Contractile and ultrastructural changes caused by oxyhemoglobin. J Neurosurg 69:9297, 1988 Fuji S, Fujitsu K: Experimental vasospasm in cultured arterial smooth-muscle cells. Part 1. Contractile and ultrastructural changes caused by oxyhemoglobin. J Neurosurg 69:92–97, 1988

    • Search Google Scholar
    • Export Citation
  • 15.

    Gibson QH, & Roughton FJW: The kinetics of equilibria of the reactions of nitric oxide with sheep haemoglobin. J Physiol 136:507526, 1957 Gibson QH, Roughton FJW: The kinetics of equilibria of the reactions of nitric oxide with sheep haemoglobin. J Physiol 136:507–526, 1957

    • Search Google Scholar
    • Export Citation
  • 16.

    Groce DF, & Kimbrough RD: Acute and subacute toxicity in sherman strain rats exposed to 4,4′- and 2,2′-dipyridyl. J Tox Envir Health 10:363372, 1982 Groce DF, Kimbrough RD: Acute and subacute toxicity in sherman strain rats exposed to 4,4′- and 2,2′-dipyridyl. J Tox Envir Health 10:363–372, 1982

    • Search Google Scholar
    • Export Citation
  • 17.

    Haley EC Jr, , Kassell NF, & Alves WM, et al: Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 82:786790, 1995 Haley EC Jr, Kassell NF, Alves WM, et al: Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 82:786–790, 1995

    • Search Google Scholar
    • Export Citation
  • 18.

    Harada T, & Mayberg MR: Inhibition of delayed arterial narrowing by the iron-chelating agent deferoxamine. J Neurosurg 77:763767, 1992 Harada T, Mayberg MR: Inhibition of delayed arterial narrowing by the iron-chelating agent deferoxamine. J Neurosurg 77:763–767, 1992

    • Search Google Scholar
    • Export Citation
  • 19.

    Hershko C, & Weatheral DJ: Iron-chelating therapy. Crit Rev Clin Lab Sci 26:303345, 1988 Hershko C, Weatheral DJ: Iron-chelating therapy. Crit Rev Clin Lab Sci 26:303–345, 1988

    • Search Google Scholar
    • Export Citation
  • 20.

    Iadecola C, , Pelligrino DA, & Moskowitz MA, et al: Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 14:175192, 1994 Iadecola C, Pelligrino DA, Moskowitz MA, et al: Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 14:175–192, 1994

    • Search Google Scholar
    • Export Citation
  • 21.

    Ignarro LJ: Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30:535560, 1990 Ignarro LJ: Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30:535–560, 1990

    • Search Google Scholar
    • Export Citation
  • 22.

    Ikeda Y, , Ikeda K, & Long DM: Comparative study of different iron-chelating agents in cold-induced brain edema. Neurosurgery 24:820824, 1989 Ikeda Y, Ikeda K, Long DM: Comparative study of different iron-chelating agents in cold-induced brain edema. Neurosurgery 24:820–824, 1989

    • Search Google Scholar
    • Export Citation
  • 23.

    Kassell NF, , Peerless SJ, & Durward QJ, et al: Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11:337343, 1982 Kassell NF, Peerless SJ, Durward QJ, et al: Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11:337–343, 1982

    • Search Google Scholar
    • Export Citation
  • 24.

    Kassell NF, , Sasaki T, & Colohan ART, et al: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16:562572, 1985 Kassell NF, Sasaki T, Colohan ART, et al: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16:562–572, 1985

    • Search Google Scholar
    • Export Citation
  • 25.

    Kawakami M, , Kodama N, & Toda N: Suppression of the cerebral vasospastic actions of oxyhemoglobin by ascorbic acid. Neurosurgery 28:3340, 1991 Kawakami M, Kodama N, Toda N: Suppression of the cerebral vasospastic actions of oxyhemoglobin by ascorbic acid. Neurosurgery 28:33–40, 1991

    • Search Google Scholar
    • Export Citation
  • 26.

    Kikuchi G, & Yoshida T: Function and induction of the microsomal heme oxygenase. Mol Cell Biochem 53/54:163183, 1983 Kikuchi G, Yoshida T: Function and induction of the microsomal heme oxygenase. Mol Cell Biochem 53/54:163–183, 1983

    • Search Google Scholar
    • Export Citation
  • 27.

    Kozlov AB, , Ostrachovitch AA, & Afanas'ev IB: Mechanism of inhibitory effects of chelating drugs on lipid peroxidation in rat brain homogenates. Biochem Pharm 47:795799, 1994 Kozlov AB, Ostrachovitch AA, Afanas'ev IB: Mechanism of inhibitory effects of chelating drugs on lipid peroxidation in rat brain homogenates. Biochem Pharm 47:795–799, 1994

    • Search Google Scholar
    • Export Citation
  • 28.

    Lamontagne D, , König A, & Bassenge E, et al: Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J Cardiovasc Pharmacol 20:652657, 1992 Lamontagne D, König A, Bassenge E, et al: Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J Cardiovasc Pharmacol 20:652–657, 1992

    • Search Google Scholar
    • Export Citation
  • 29.

    Macdonald RL, & Weir BKA: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971982, 1991 Macdonald RL, Weir BKA: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971–982, 1991

    • Search Google Scholar
    • Export Citation
  • 30.

    Macdonald RL, , Weir BKA, & Runzer TD, et al: Etiology of cerebral vasospasm in primates. J Neurosurg 75:415424, 1991 Macdonald RL, Weir BKA, Runzer TD, et al: Etiology of cerebral vasospasm in primates. J Neurosurg 75:415–424, 1991

    • Search Google Scholar
    • Export Citation
  • 31.

    Moncada S, , Palmer RMJ, & Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109142, 1991 Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109–142, 1991

    • Search Google Scholar
    • Export Citation
  • 32.

    Nunez MT, , Cole ES, & Glass J: The reticulocyte plasma membrane pathway or iron uptake as determined by the mechanism of α-α′-dipyridyl inhibition. J Biol Chem 258:11461151, 1982 Nunez MT, Cole ES, Glass J: The reticulocyte plasma membrane pathway or iron uptake as determined by the mechanism of α-α′-dipyridyl inhibition. J Biol Chem 258:1146–1151, 1982

    • Search Google Scholar
    • Export Citation
  • 33.

    Oudibar M, , Boquillon M, & Marie C, et al: Ischemia-induced brain iron delocalization: effect of iron chelators. Free Rad Biol Med 16:861867, 1994 Oudibar M, Boquillon M, Marie C, et al: Ischemia-induced brain iron delocalization: effect of iron chelators. Free Rad Biol Med 16:861–867, 1994

    • Search Google Scholar
    • Export Citation
  • 34.

    Pearce W: Mechanism of hypoxic and hypercapnic cerebral vasodilation, in Bevan RD, & Bevan JA (eds): The Human Brain Circulation. Functional Changes in Disease. Totawa, NJ: Humana Press, 1994, pp 195200 Pearce W: Mechanism of hypoxic and hypercapnic cerebral vasodilation, in Bevan RD, Bevan JA (eds): The Human Brain Circulation. Functional Changes in Disease. Totawa, NJ: Humana Press, 1994, pp 195–200

    • Search Google Scholar
    • Export Citation
  • 35.

    Peters G, , Keberle H, & Schmid K, et al: Distribution and renal excretion of desferrioxamine and ferrioxamine in the dog and in the rat. Biochem Pharmacol 15:93109, 1966 Peters G, Keberle H, Schmid K, et al: Distribution and renal excretion of desferrioxamine and ferrioxamine in the dog and in the rat. Biochem Pharmacol 15:93–109, 1966

    • Search Google Scholar
    • Export Citation
  • 36.

    Pirisino R, , DiSimplico P, & Ignesti G, et al: Sulfhydryl groups and peroxidase-like activity of albumin as scavenger of organic peroxides. Pharmacol Res Commun 20:545552, 1988 Pirisino R, DiSimplico P, Ignesti G, et al: Sulfhydryl groups and peroxidase-like activity of albumin as scavenger of organic peroxides. Pharmacol Res Commun 20:545–552, 1988

    • Search Google Scholar
    • Export Citation
  • 37.

    Pluta RM, , Oldfield EH, & Boock RJ: Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg 87:746751, 1997 Pluta RM, Oldfield EH, Boock RJ: Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg 87:746–751, 1997

    • Search Google Scholar
    • Export Citation
  • 38.

    Pluta RM, , Thompson BG, & Dawson TM, et al: Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg 84:648654, 1996 Pluta RM, Thompson BG, Dawson TM, et al: Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg 84:648–654, 1996

    • Search Google Scholar
    • Export Citation
  • 39.

    Pluta RM, , Zauner A, & Morgan JK, et al: Is vasospasm related to proliferative arteriopathy? J Neurosurg 77:740748, 1992 Pluta RM, Zauner A, Morgan JK, et al: Is vasospasm related to proliferative arteriopathy? J Neurosurg 77:740–748, 1992

    • Search Google Scholar
    • Export Citation
  • 40.

    Sano K, , Asano T, & Tanishima T, et al: Lipid peroxidase as a cause of cerebral vasospasm. Neurol Res 2:253272, 1980 Sano K, Asano T, Tanishima T, et al: Lipid peroxidase as a cause of cerebral vasospasm. Neurol Res 2:253–272, 1980

    • Search Google Scholar
    • Export Citation
  • 41.

    Sasaki T, , Asano T, & Sano K: [Cerebral vasospasm and free radical reactions.] Neurol Med Chir 20:145153, 1980 (Jpn) Sasaki T, Asano T, Sano K: [Cerebral vasospasm and free radical reactions.] Neurol Med Chir 20:145–153, 1980 (Jpn)

    • Search Google Scholar
    • Export Citation
  • 42.

    Sonobe M, & Suzuki J: Vasospasmogenic substance produced following subarachnoid haemorrhage, and its fate. Acta Neurochir 44:97106, 1978 Sonobe M, Suzuki J: Vasospasmogenic substance produced following subarachnoid haemorrhage, and its fate. Acta Neurochir 44:97–106, 1978

    • Search Google Scholar
    • Export Citation
  • 43.

    Stone JR, & Marletta MA: Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry 33:56365640, 1994 Stone JR, Marletta MA: Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry 33:5636–5640, 1994

    • Search Google Scholar
    • Export Citation
  • 44.

    Takeda A, , Onodera H, & Sugimoto A, et al: Increased expression of heme oxygenase mRNA in rat brain following transient forebrain ischemia. Brain Res 666:120124, 1994 Takeda A, Onodera H, Sugimoto A, et al: Increased expression of heme oxygenase mRNA in rat brain following transient forebrain ischemia. Brain Res 666:120–124, 1994

    • Search Google Scholar
    • Export Citation
  • 45.

    Toda N, , Ayajiki K, & Yoshida K, et al: Impairment by damage of the pterygopalatine ganglion in nitroxidergic vasodilator nerve function in canine cerebral and retinal arteries. Circ Res 72:206213, 1993 Toda N, Ayajiki K, Yoshida K, et al: Impairment by damage of the pterygopalatine ganglion in nitroxidergic vasodilator nerve function in canine cerebral and retinal arteries. Circ Res 72:206–213, 1993

    • Search Google Scholar
    • Export Citation
  • 46.

    Vane JR, , Änggård EE, & Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 323:2736, 1990 Vane JR, Änggård EE, Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 323:27–36, 1990

    • Search Google Scholar
    • Export Citation
  • 47.

    Vollmer DG, , Hongo K, & Ogawa H, et al: A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage. Neurosurgery 28:2732, 1991 Vollmer DG, Hongo K, Ogawa H, et al: A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage. Neurosurgery 28:27–32, 1991

    • Search Google Scholar
    • Export Citation
  • 48.

    Weir B, , Grace M, & Hansen J, et al: Time course of vasospasm in man. J Neurosurg 48:173178, 1978 Weir B, Grace M, Hansen J, et al: Time course of vasospasm in man. J Neurosurg 48:173–178, 1978

    • Search Google Scholar
    • Export Citation
  • 49.

    Weir B, & Macdonald L: Cerebral vasospasm. Clin Neurosurg 40:4055, 1993 Weir B, Macdonald L: Cerebral vasospasm. Clin Neurosurg 40:40–55, 1993

    • Search Google Scholar
    • Export Citation
  • 50.

    Yosha T, , Kobayashi Y, & Masuko T: Differential effects of 3 dipyridyl isomers on hepatic microsomal cytochrome P450 and heme oxygenase in rat. Toxicol Lett 76:145153, 1995 Yosha T, Kobayashi Y, Masuko T: Differential effects of 3 dipyridyl isomers on hepatic microsomal cytochrome P450 and heme oxygenase in rat. Toxicol Lett 76:145–153, 1995

    • Search Google Scholar
    • Export Citation
  • 51.

    Young DS: Effects of Drugs on Clinical Laboratory Tests, ed 4. Washington, DC: AACC Press, 1995 Young DS: Effects of Drugs on Clinical Laboratory Tests, ed 4. Washington, DC: AACC Press, 1995

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 618 177 4
Full Text Views 256 25 0
PDF Downloads 139 20 0
EPUB Downloads 0 0 0